Monocyte chemoattractant protein-1 (MCP-1/CCL2) and matrix metalloproteinase-9 (MMP-9) as biomarkers of disease severity in COVID-19 patients
MMP9 and CCL2 could be a potential clinical biomarker for patients with COVID-19. Regulation of these immune elements may be complex and responsible mechanisms deserve further investigation.
Authors
- Mostafa Javanian (ORCID: https://orcid.org/0000-0002-2771-4578)
- Sheyda Mohammadkhani
- Abbas Azadmehr
- Moein Shirzad
- Morteza Oladnabi
- Kiarash Saleki
Institutions
- Universal Scientific Education and Research Network (IR)
- Golestan University of Medical Sciences (IR)
- Iran's National Elites Foundation (IR)
- Babol University of Medical Sciences (IR)
Publication Details
- Journal
- Biochemistry and Biophysics Reports
- Published
- 2026-02-18
- DOI
- https://doi.org/10.1016/j.bbrep.2026.102505
- Primary Topic
- Chemokine receptors and signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00